CARLSBAD– Arima Genomics recently bolstered its strategic focus on its core clinical diagnostic platform, announcing an exclusive distribution partnership with genomics services company Active Motif Inc. The agreement gives Active Motif exclusive distribution rights for Arima’s full suite of three-dimensional genomics research kits and services outside of the company’s formalin-fixed paraffin-embedded platform for cancer diagnostics. […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.